PharmaSens与SiBionics达成开发合作协议，共同推进用于糖尿病管理的全合一贴片泵技术-动脉网

PharmaSens and SiBionics Enter Development Collaboration to Advance All-in-One Patch Pump for Diabetes Management

CISION 等信源发布 2025-06-19 20:03



可切换为仅中文







Companies will jointly develop niia™ signature, an all-in-one wearable insulin patch pump that provides integrated insulin delivery with real-time glucose sensing

公司将联合开发niia™ signature，这是一款集胰岛素输送与实时血糖监测于一体的全功能可穿戴胰岛素贴片泵。

Collaboration aims to reduce daily burden for people with diabetes through simplified therapy

通过简化治疗，合作旨在减轻糖尿病患者的日常负担。

BIEL/BIENNE,

比尔/比恩，

Switzerland

瑞士

，

June 19, 2025

2025年6月19日

/PRNewswire/ -- PharmaSens AG, a Swiss developer of next-generation insulin patch pump systems, announced a strategic partnership with SiBionics, a leading provider of continuous glucose monitoring (CGM) technologies. The two companies will jointly develop the next-generation

/PRNewswire/ -- 瑞士下一代胰岛素贴片泵系统开发商PharmaSens AG宣布与领先的连续血糖监测（CGM）技术提供商SiBionics建立战略合作伙伴关系。两家公司将共同开发下一代

niia™ signature

niia™ 签名

— an all-in-one wearable device that integrates insulin delivery and glucose sensing into a single compact patch pump.

—— 一款集胰岛素输送和血糖感应于一体的紧凑型贴片泵全能可穿戴设备。

Through this strategic collaboration, PharmaSens and SiBionics aim to simplify diabetes management by combining their respective strengths in insulin-delivery innovation and CGM technology. The new

通过这一战略合作，PharmaSens 和 SiBionics 旨在结合各自在胰岛素输送创新和持续血糖监测技术方面的优势，简化糖尿病管理。新的

niia™ signature

尼娅™ 签名

will offer an unprecedented level of convenience and user experience for individuals who use insulin to manage their diabetes, with the goal of reducing the daily burden of therapy.

将为使用胰岛素管理糖尿病的患者提供前所未有的便利性和用户体验，旨在减轻治疗的日常负担。

'This partnership marks a significant milestone toward realizing our vision of a fully integrated, discreet, and intuitive insulin-therapy system,' said

“这一合作标志着我们朝着实现全集成、隐蔽且直观的胰岛素治疗系统的愿景迈出了重要的里程碑，”

Marcel Both

马塞尔·博特

, CEO of PharmaSens. 'SiBionics' proven expertise in sensor technology is a perfect complement to our platform.'

PharmaSens首席执行官表示：“SiBionics在传感器技术方面的成熟专业知识是对我们平台的完美补充。”

The new

新的

niia™ signature

尼娅™ 签名

device will build on PharmaSens' patented platform technologies and SiBionics' advanced biosensor capabilities, with both companies contributing engineering and development expertise to bring this all-in-one wearable patch pump to market.

该设备将基于 PharmaSens 的专利平台技术和 SiBionics 的先进生物传感器能力，两家公司将贡献工程和开发专业知识，以将这款一体化可穿戴贴片泵推向市场。

About PharmaSens

关于PharmaSens

PharmaSens AG, a privately owned Swiss company, is dedicated to simplifying diabetes management and broadening the reach of insulin pump therapy. The PharmaSens team has a wealth of experience in diabetes care and medtech device engineering, having contributed to the development of multiple insulin pump generations.

PharmaSens AG 是一家私人拥有的瑞士公司，致力于简化糖尿病管理并扩大胰岛素泵疗法的覆盖范围。PharmaSens 团队在糖尿病护理和医疗技术设备工程方面拥有丰富的经验，曾为多代胰岛素泵的开发做出贡献。

Over several years of research and development, PharmaSens has built a patented international portfolio of distinctive and innovative products. For more information, please visit .

经过多年的研究和开发，PharmaSens 已经建立了一个拥有专利的、独具特色且创新的国际产品组合。欲了解更多信息，请访问。

PharmaSens.com

。

About SiBionics

关于SiBionics

Founded in 2015, SiBionics is a leading medical device company with offices in

成立于2015年，SiBionics是一家领先的医疗设备公司，办公地点位于

Shenzhen, China

中国深圳

, and

，以及

Irvine, California

加利福尼亚州欧文市

. SiBionics core expertise lies in medical device research, development, and innovation. With a team of over 500 employees—more than 25% of whom are R&D scientists from top universities in

SiBionics的核心专长在于医疗设备的研究、开发与创新。公司拥有超过500名员工，其中超过25%是来自顶尖大学的研发科学家。

China

中国

and the U.S.—SiBionics is dedicated to advancing healthcare technology.

美国——思博医疗致力于推进医疗技术的发展。

The SiBionics mission is to transform patients' lives by providing them with deeper insights into their health through the integration of cutting-edge continuous biosensors, intelligent algorithms, and user-friendly software solutions. Learn more at

SiBionics 的使命是通过整合尖端的连续生物传感器、智能算法和用户友好的软件解决方案，为患者提供更深入的健康洞察，从而改变他们的生活。欲了解更多信息，请访问

www.sibionicscgm.com

。

Media Contacts:

媒体联系人：

In the U.S.

在美国

Michele Parisi, SignalWest Public Relations/Forward Health

米凯莱·帕里西，SignalWest 公共关系/Forward Health

mparisi@forwardhealthinc.com

Mobile: +1 (925) 864-5028

手机：+1 (925) 864-5028